Rajendra S. Apte, MD, PhD
Current Position
Assistant Professor, Ophthalmology and Visual Sciences
Specialty Areas
Ophthalmology, Retina
Retina
Mailing Address
|
Washington University School of Medicine
Department of Ophthalmology and Visual Sciences
660 So. Euclid Avenue, Campus Box 8096
St. Louis,
MO
63110
|
Areas of Clinical Interest
Diabetic retinopathy, macular surgery, macular holes, macular pucker, age-related macular degeneration, vitreous substitutes, retinal detachments
Board Certification
Ophthalmology
--
Certified
Medical Education
Pre-Med: University of Bombay, Bombay, India, 1986
Medical Degree: L.T.M. Medical College, University of Bombay, Bombay, India, 1992
Ph.D.: Cellular and Molecular Biology, University of Texas Southwestern Medical Center, Dallas, Texas, 1997
Residency: Ophthalmology, UT Southwestern Medical Center, Dallas, Texas , 2001
Fellowship: Retinal Vascular, Wilmer Ophthalmological Institute, Baltimore, Maryland, 2002
Fellowship: Vitreoretinal, Wilmer Ophthalmological Institute, Baltimore, Maryland, 2003
Hospital Affiliations
Barnes-Jewish Hospital
Major or Recent Publications/Awards
Awards and Honors
Washington University Nominee for the Ellison Foundation New Scholars Award in Aging, 2005
Research to Prevent Blindness Career Development Award, 2004
Fellow, American Academy of Ophthalmology, 2003
Disclosure of Financial Interests with IndustryWashington University and its physicians are committed to ensuring integrity and objectivity in medical decision-making. Some of our physicians work collaboratively with pharmaceutical or medical device companies to develop innovative ideas and products that can improve health care delivery and clinical outcomes for patients. In some instances, our faculty physicians are paid by these commercial companies to provide advice on product design or to speak about the use of medications, devices, equipment or procedures. These payments may include: a) compensation for consulting and speaking engagements, b) equity, and/or c) royalties for products invented by our faculty. Any payments to Washington University physicians must be based on tangible services and may not exceed fair market value for their work. In addition to disclosure on this web site, physicians earning more than $10,000 per year must disclose their corporate financial relationship in writing to patients when prescribing or using that company's products.
Dr. Rajendra S. Apte reported the following earned financial interests during calendar year 2009. Move your mouse over a header for more info.
| Company | Royalties Royalties: When a faculty member invents or conceives a new or improved process or product, the company that manufactures the product will make royalty payments to the faculty member. Royalty payments usually are a small percentage of the company’s revenue related to that product. | Equity Equity: Equity is an ownership interest in a company. Faculty members may be paid for their service to a company in stock or the option to obtain stock. | Consulting &
Advisory Boards Consulting and Advisory Boards: Faculty may be paid to provide expertise to a company by being their consultant, or by serving on an advisory board. | Speaker Fees Speaker Fees: Companies may pay faculty to speak to professional audiences about their products. |
| Eyetech | | | $1K-$10K | $10K-25K |
| Ophthotech | | Yes | | |
| Genentech | | | $1K-$10K | $10K-25K |
To learn more about Washington University's policies on collaborations with industry,
click here.
Peer Reviewed Manuscripts
Yu J, Apte RS. A case of intravitreal silicone oil migration to the central nervous system. Retina, In press
Oshima Y, Oshima S, Nambu H, Kachi S, Takahashi K, Umeda N, Shen J, Apte RS, et al. Different Effects of Angiopoietin-2 in Different Vascular Beds in the Eye; New Vessels are more Sensitive. FASEB Journal, 2005;19:963-5
Hariprasad SM, Blinder KJ, Shah GK, Apte RS, Holekamp NM, Thomas MA, Mieler WF, Chi J, Prince RA. Penetration pharmacokinetics of topically administered 0.5% moxifloxacin ophthalmic solution in human aqueous and vitreous. Arch Ophthalmol, 2005;123:39-44
Apte RS, Al-Abdulla N, Green WR, Schachat AP, DeJong MR, DiBernardo C, Handa JT. Systemic non-Hodgkin B-cell lymphoma presenting as a vanishing choroidal mass. Arch Ophthalmol, 2005;123:105-109
Apte RS, Schachat AP, DiBernardo C, Handa JT. Retinal vascular occlusion with overlying vitreous hemorrhage masquerading as a tumor. Arch Ophthalmol, 2005;123:272-274
Apte RS, DiBernardo C, Pearlman JR, Patel S, Schachat AP, Green WR, Gehlbach P. Retinal metastasis presenting as a retinal hemorrhage in a patient with adenocarcinoma of the cecum. Arch Ophthalmol, 2005;123:105-109
Apte RS, Barreiro RA, Duh E, Volpert O, Ferguson TA. Stimulation of neovascularization by the anti-angiogenic factor PEDF. Inv Ophthalmol Vis Sci, 2004;45:4491-4497.
Blair MP, Apte RS, Miskala PM, Bressler SB, Goldberg MF, Schachat AP, Bressler NM. A retrospective case series of juxtafoveal choroidal neovascularization treated with photodynamic therapy with verteporfin. Retina, 2004;24:501-506.
Hariprasad SM, Mieler WF, Blinder KJ, Shah GK, Apte RS, Holekamp NM, Thomas MA, Chi J, Prince RA. Human aqueous and vitreous penetration pharmacokinetics of moxifloxacin 0.5% ophthalmic solution via topical and collagen shield routes of administration. Tr Am Ophth Soc, 2004;102:149-155
Louie K, Apte RS, Mori K, Gehlbach PL. Severe proliferative retinopathy in a patient with Duchenne Muscular Dystrophy. Br J Ophthalmol, 2004;88:1604-1605
Apte RS, Bressler NM. Foveal congenital hypertrophy of the retinal pigment epithelium in the setting of geographic atrophy from age-related macular degeneration. Am J Ophthalmol 2003; 135:120-121
Apte RS, Sung JU, DiBernardo C, Greenberg E. Giant neurosensory detachments in neovascular age-related macular degeneration. Br J Ophthalmol 2003; 87:795-796
Margalit E, Apte RS. Submacular surgery for choroidal neovascularization. Bombay Hosp J 2002; 44(3)
Apte RS, Sadda SR. Diabetes and ocular disease: implications for clinical practice. Contemporary Ophthalmol 2002; 1(21):1-8
Margalit E, Apte RS, Sadda SR. Idiopathic parafoveal telangiectasis associated with a foveal pseudovitelliform lesion: a case report. Br J Ophthalmol 2002; 86:1455-1456
Apte RS, Margalit E. Role of photodynamic therapy in the management of age-related macular degeneration. Bombay Hosp J 2002; 44(3)
Apte RS, Niederkorn JY, Mayhew E, Alizadeh H. Angiostatin produced by certain primary uveal melanoma cell lines impedes the development of liver metastases. Arch Ophthalmol 2001; 119:1805-1809
Apte RS, Scheufele TA, Blomquist PH. Etiology of blindness in an urban community hospital setting. Ophthalmology 2001; 108:693-696
For more articles and abstracts, take this off-site link to the National Library of Medicine Pub Med page for Dr. Rajendra S. Apte